Author: Dr. David Lowemann

Moderna’s Melanoma Vaccine Could Launch Next Year

Pharmaceutical giant Moderna plans to launch a messenger RNA-based vaccine for skin cancer in 2025. It says it has developed an mRNA vaccine with similar technology to its COVID-19 vaccine that is proving to be effective against melanoma.v”Phase 2 data is available,”… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]

Published on September 16, 2024

Incremental Discourse‐Update Constrains Number Agreement Attraction Effect

Abstract While a large body of work in sentence comprehension has explored how different types of linguistic information are used to guide syntactic parsing, less is known about the effect of discourse structure. This study investigates this question, focusing on the main and subordinate discourse contrast manifested in the distinction between restrictive relative clauses (RRCs) […]

Published on September 16, 2024

Latent Relations at Steady‐state with Associative Nets

Abstract Models of word meaning that exploit patterns of word usage across large text corpora to capture semantic relations, like the topic model and word2vec, condense word-by-context co-occurrence statistics to induce representations that organize words along semantically relevant dimensions (e.g., synonymy, antonymy, hyponymy, etc.). However, their reliance on latent representations leaves them vulnerable to interference, […]

Published on September 16, 2024